AN Phillips

4.7k total citations · 2 hit papers
40 papers, 3.5k citations indexed

About

AN Phillips is a scholar working on Infectious Diseases, Virology and Emergency Medicine. According to data from OpenAlex, AN Phillips has authored 40 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Infectious Diseases, 25 papers in Virology and 10 papers in Emergency Medicine. Recurrent topics in AN Phillips's work include HIV/AIDS Research and Interventions (33 papers), HIV Research and Treatment (25 papers) and HIV/AIDS drug development and treatment (22 papers). AN Phillips is often cited by papers focused on HIV/AIDS Research and Interventions (33 papers), HIV Research and Treatment (25 papers) and HIV/AIDS drug development and treatment (22 papers). AN Phillips collaborates with scholars based in United Kingdom, Denmark and Italy. AN Phillips's co-authors include Jens Lundgren, Amanda Mocroft, Antonella d’Arminio Monforte, Ole Kirk, Christine Katlama, Antonio Chiesi, Bruno Ledergerber, Peter Reiss, Stefano Vella and Brygida Knysz and has published in prestigious journals such as The Lancet, American Journal of Ophthalmology and Public Health.

In The Last Decade

AN Phillips

40 papers receiving 3.4k citations

Hit Papers

Changing patterns of mortality across Europe in patients ... 1998 2026 2007 2016 1998 2003 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
AN Phillips United Kingdom 23 2.8k 1.8k 1.3k 1.1k 232 40 3.5k
Kathleen C. Wood United States 20 2.2k 0.8× 1.2k 0.7× 1.3k 1.0× 1.5k 1.4× 150 0.6× 29 3.3k
Benjamin Young United States 29 2.0k 0.7× 1.3k 0.7× 699 0.6× 1.1k 1.0× 115 0.5× 91 3.0k
William Towner United States 27 2.3k 0.8× 1.3k 0.7× 1.2k 0.9× 1.1k 1.0× 549 2.4× 80 3.6k
Kholoud Porter United Kingdom 39 3.5k 1.2× 2.5k 1.5× 1.8k 1.4× 1.0k 0.9× 231 1.0× 138 4.6k
Frank de Wolf Netherlands 26 2.8k 1.0× 2.1k 1.2× 1.1k 0.9× 653 0.6× 90 0.4× 41 5.2k
Gitte Pedersen Denmark 26 1.5k 0.5× 708 0.4× 1.1k 0.9× 1.0k 0.9× 334 1.4× 89 2.8k
François Dabis France 28 2.4k 0.8× 1.4k 0.8× 1.4k 1.1× 969 0.9× 104 0.4× 67 3.3k
Mhairi Maskew South Africa 34 3.1k 1.1× 1.3k 0.8× 1.6k 1.3× 687 0.6× 187 0.8× 130 3.8k
Katherine Huppler Hullsiek United States 31 1.6k 0.6× 1.2k 0.7× 1.1k 0.9× 672 0.6× 312 1.3× 52 2.9k
Marc van der Valk Netherlands 39 2.6k 0.9× 1.9k 1.1× 1.6k 1.3× 1.3k 1.2× 156 0.7× 212 4.6k

Countries citing papers authored by AN Phillips

Since Specialization
Citations

This map shows the geographic impact of AN Phillips's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by AN Phillips with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites AN Phillips more than expected).

Fields of papers citing papers by AN Phillips

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by AN Phillips. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by AN Phillips. The network helps show where AN Phillips may publish in the future.

Co-authorship network of co-authors of AN Phillips

This figure shows the co-authorship network connecting the top 25 collaborators of AN Phillips. A scholar is included among the top collaborators of AN Phillips based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with AN Phillips. AN Phillips is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dunn, David, Peter Weatherburn, Fiona Lampe, et al.. (2020). Sexual risk and HIV testing disconnect in men who have sex with men (MSM) recruited to an online HIV self‐testing trial. HIV Medicine. 21(9). 588–598. 9 indexed citations
3.
Stirrup, Oliver, Andrew Copas, AN Phillips, et al.. (2017). Predictors of CD4 cell recovery following initiation of antiretroviral therapy among HIV‐1 positive patients with well‐estimated dates of seroconversion. HIV Medicine. 19(3). 184–194. 34 indexed citations
4.
Cozzi‐Lepri, Alessandro, AN Phillips, Bonaventura Clotet, et al.. (2011). The rate of accumulation of nonnucleoside reverse transcriptase inhibitor (NNRTI) resistance in patients kept on a virologically failing regimen containing an NNRTI*. HIV Medicine. 13(1). 62–72. 24 indexed citations
5.
Hughes, Rachael A., Jonathan A C Sterne, John Walsh, et al.. (2011). Long-term trends in CD4 cell counts and impact of viral failure in individuals starting antiretroviral therapy: UK Collaborative HIV Cohort (CHIC) study. HIV Medicine. 12(10). 583–593. 25 indexed citations
6.
Leen, Clifford, Jonathan Ainsworth, J. Anderson, et al.. (2009). Tuberculosis among people with HIV infection in the United Kingdom: opportunities for prevention? United Kingdom Collaborative HIV Cohort Study Group. UCL Discovery (University College London). 7 indexed citations
7.
Madge, Sara, Colette Smith, Fiona Lampe, et al.. (2008). An audit of viral load in one clinical population to describe features of viraemic patients on antiretroviral therapy. HIV Medicine. 9(4). 208–213. 4 indexed citations
9.
Easterbrook, Philippa, AN Phillips, Teresa Hill, et al.. (2008). Patterns and predictors of the use of different antiretroviral drug regimens at treatment initiation in the UK. HIV Medicine. 9(1). 47–56. 22 indexed citations
10.
Shah, Sapna, Colette Smith, Fiona Lampe, et al.. (2007). Haemoglobin and albumin as markers of HIV disease progression in the highly active antiretrovial therapy era: relationships with gender*. HIV Medicine. 8(1). 38–45. 37 indexed citations
11.
Olsen, Christian Holkmann, Amanda Mocroft, Ole Kirk, et al.. (2007). Interruption of combination antiretroviral therapy and risk of clinical disease progression to AIDS or death. HIV Medicine. 8(2). 96–104. 69 indexed citations
12.
Phillips, AN, Caroline Sabin, Deenan Pillay, & Jens Lundgren. (2007). HIV in the UK 1980–2006: reconstruction using a model of HIV infection and the effect of antiretroviral therapy. HIV Medicine. 8(8). 536–546. 26 indexed citations
13.
14.
Stöhr, Wolfgang, David Dunn, Kholoud Porter, et al.. (2007). CD4 cell count and initiation of antiretroviral therapy: trends in seven UK centres, 1997–2003. HIV Medicine. 8(3). 135–141. 33 indexed citations
15.
Sabin, Caroline, Fiona Lampe, Clinton Chaloner, et al.. (2003). An audit of antiretroviral treatment use in HIV‐infected patients in a London clinic: the limitations of observational databases when auditing antiretroviral treatment use. HIV Medicine. 4(2). 87–93. 33 indexed citations
16.
Lloyd-Owen, S.J., et al.. (2002). The changing demographics of new HIV diagnoses at a London centre from 1994 to 2000. HIV Medicine. 3(2). 129–134. 23 indexed citations
17.
Phillips, AN, S Staszewski, Rainer Weber, et al.. (2000). Viral toad changes in response to antiretroviral therapy according to the baseline CD4 lymphocyte count and viral load. UCL Discovery (University College London). 3 indexed citations
18.
Mocroft, Amanda, Christine Katlama, Margaret Johnson, et al.. (2000). AIDS across Europe, 1994–98: the EuroSIDA study. The Lancet. 356(9226). 291–296. 347 indexed citations
19.
Mocroft, Amanda, Stefano Vella, Thomas Benfield, et al.. (1998). Changing patterns of mortality across Europe in patients infected with HIV-1. The Lancet. 352(9142). 1725–1730. 1048 indexed citations breakdown →
20.
Youle, M, et al.. (1997). Anti-herpesvirus treatment and risk of Kaposi's sarcoma in HIV infection.. American Journal of Ophthalmology. 123(1). 150–150. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026